Dose-finding Study in Platinum-Resistant Ovarian Cancer

Clinical trial NCT01653912 · COMPLETED

Trial details

NCT number: NCT01653912
Sponsor: Accenture
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Recurrent Platinum-resistant Ovarian Cancer

Start date: 2012-11-01
Primary completion: 2015-07-01
Enrollment: 59

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.